Current understanding of epigenetics role in melanoma treatment and resistance

Abstract Melanoma is the most aggressive form of skin cancer resulting from genetic mutations in melanocytes. Several factors have been considered to be involved in melanoma progression, including genetic alteration, processes of damaged DNA repair, and changes in mechanisms of cell growth and proli...

Full description

Bibliographic Details
Main Authors: Mohsen Karami Fath, Ali Azargoonjahromi, Asma Soofi, Faezeh Almasi, Shahnaz Hosseinzadeh, Saeed Khalili, Kamran Sheikhi, Saeid Ferdousmakan, Soroor Owrangi, Minoovash Fahimi, Hamidreza Zalpoor, Mohsen Nabi Afjadi, Zahra Payandeh, Navid Pourzardosht
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-022-02738-0
_version_ 1811238859780915200
author Mohsen Karami Fath
Ali Azargoonjahromi
Asma Soofi
Faezeh Almasi
Shahnaz Hosseinzadeh
Saeed Khalili
Kamran Sheikhi
Saeid Ferdousmakan
Soroor Owrangi
Minoovash Fahimi
Hamidreza Zalpoor
Mohsen Nabi Afjadi
Zahra Payandeh
Navid Pourzardosht
author_facet Mohsen Karami Fath
Ali Azargoonjahromi
Asma Soofi
Faezeh Almasi
Shahnaz Hosseinzadeh
Saeed Khalili
Kamran Sheikhi
Saeid Ferdousmakan
Soroor Owrangi
Minoovash Fahimi
Hamidreza Zalpoor
Mohsen Nabi Afjadi
Zahra Payandeh
Navid Pourzardosht
author_sort Mohsen Karami Fath
collection DOAJ
description Abstract Melanoma is the most aggressive form of skin cancer resulting from genetic mutations in melanocytes. Several factors have been considered to be involved in melanoma progression, including genetic alteration, processes of damaged DNA repair, and changes in mechanisms of cell growth and proliferation. Epigenetics is the other factor with a crucial role in melanoma development. Epigenetic changes have become novel targets for treating patients suffering from melanoma. These changes can alter the expression of microRNAs and their interaction with target genes, which involves cell growth, differentiation, or even death. Given these circumstances, we conducted the present review to discuss the melanoma risk factors and represent the current knowledge about the factors related to its etiopathogenesis. Moreover, various epigenetic pathways, which are involved in melanoma progression, treatment, and chemo-resistance, as well as employed epigenetic factors as a solution to the problems, will be discussed in detail.
first_indexed 2024-04-12T12:48:22Z
format Article
id doaj.art-90b9c0e0d05c4be9a40ab65b8f419d7f
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-04-12T12:48:22Z
publishDate 2022-10-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-90b9c0e0d05c4be9a40ab65b8f419d7f2022-12-22T03:32:32ZengBMCCancer Cell International1475-28672022-10-0122112310.1186/s12935-022-02738-0Current understanding of epigenetics role in melanoma treatment and resistanceMohsen Karami Fath0Ali Azargoonjahromi1Asma Soofi2Faezeh Almasi3Shahnaz Hosseinzadeh4Saeed Khalili5Kamran Sheikhi6Saeid Ferdousmakan7Soroor Owrangi8Minoovash Fahimi9Hamidreza Zalpoor10Mohsen Nabi Afjadi11Zahra Payandeh12Navid Pourzardosht13Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Kharazmi UniversityShiraz University of Medical SciencesDepartment of Physical Chemistry, School of Chemistry, College of Sciences, University of TehranPharmaceutical Biotechnology Lab, Department of Microbial Biotechnology, School of Biology and Center of Excellence in Phylogeny of Living Organisms, College of Science, University of TehranDepartment of Microbiology, Parasitology and Immunology, Ardabil University of Medical SciencesDepartment of Biology Sciences, Shahid Rajaee Teacher Training UniversitySchool of Medicine, Kurdistan University of Medical SciencesDepartment of Pharmacy Practice, Nargund College of PharmacyStudent Research Committe, Fasa University of Medical SciencesFaculty of Medicine, Comenius UniversityShiraz Neuroscience Research Center, Shiraz University of Medical SciencesDepartment of Biochemistry, Faculty of Biological Science, Tarbiat Modares UniversityDepartment Medical Biochemistry and Biophysics, Division Medical Inflammation Research, Karolinska InstituteBiochemistry Department, Guilan University of Medical SciencesAbstract Melanoma is the most aggressive form of skin cancer resulting from genetic mutations in melanocytes. Several factors have been considered to be involved in melanoma progression, including genetic alteration, processes of damaged DNA repair, and changes in mechanisms of cell growth and proliferation. Epigenetics is the other factor with a crucial role in melanoma development. Epigenetic changes have become novel targets for treating patients suffering from melanoma. These changes can alter the expression of microRNAs and their interaction with target genes, which involves cell growth, differentiation, or even death. Given these circumstances, we conducted the present review to discuss the melanoma risk factors and represent the current knowledge about the factors related to its etiopathogenesis. Moreover, various epigenetic pathways, which are involved in melanoma progression, treatment, and chemo-resistance, as well as employed epigenetic factors as a solution to the problems, will be discussed in detail.https://doi.org/10.1186/s12935-022-02738-0MelanomaEpigeneticsDrug resistanceImmunotherapy
spellingShingle Mohsen Karami Fath
Ali Azargoonjahromi
Asma Soofi
Faezeh Almasi
Shahnaz Hosseinzadeh
Saeed Khalili
Kamran Sheikhi
Saeid Ferdousmakan
Soroor Owrangi
Minoovash Fahimi
Hamidreza Zalpoor
Mohsen Nabi Afjadi
Zahra Payandeh
Navid Pourzardosht
Current understanding of epigenetics role in melanoma treatment and resistance
Cancer Cell International
Melanoma
Epigenetics
Drug resistance
Immunotherapy
title Current understanding of epigenetics role in melanoma treatment and resistance
title_full Current understanding of epigenetics role in melanoma treatment and resistance
title_fullStr Current understanding of epigenetics role in melanoma treatment and resistance
title_full_unstemmed Current understanding of epigenetics role in melanoma treatment and resistance
title_short Current understanding of epigenetics role in melanoma treatment and resistance
title_sort current understanding of epigenetics role in melanoma treatment and resistance
topic Melanoma
Epigenetics
Drug resistance
Immunotherapy
url https://doi.org/10.1186/s12935-022-02738-0
work_keys_str_mv AT mohsenkaramifath currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT aliazargoonjahromi currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT asmasoofi currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT faezehalmasi currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT shahnazhosseinzadeh currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT saeedkhalili currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT kamransheikhi currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT saeidferdousmakan currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT soroorowrangi currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT minoovashfahimi currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT hamidrezazalpoor currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT mohsennabiafjadi currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT zahrapayandeh currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance
AT navidpourzardosht currentunderstandingofepigeneticsroleinmelanomatreatmentandresistance